Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,066 | 3,477 | 4,115 | 4,385 | 6,462 |
| Marketable Securities | 36,561 | 35,725 | 36,880 | 33,266 | 33,199 |
| Receivables | 5,884 | 1,848 | 1,033 | 739 | 248 |
| Inventories | 55 | 0 | 0 | 0 | 0 |
| Other current assets | 191 | 482 | 394 | 216 | 202 |
| TOTAL | $43,757 | $41,532 | $42,422 | $38,606 | $40,111 |
| Non-Current Assets | |||||
| PPE Net | 12,083 | 11,959 | 11,398 | 11,095 | 10,600 |
| Other Non-Current Assets | 146 | 145 | 97 | 97 | 97 |
| TOTAL | $12,229 | $12,104 | $11,495 | $11,192 | $10,697 |
| Total Assets | $50,843 | $48,744 | $49,299 | $45,429 | $46,672 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 408 | 599 | 468 | 445 | 273 |
| Accrued Expenses | 1,214 | 610 | 419 | 545 | 948 |
| TOTAL | $1,772 | $1,209 | $1,262 | $990 | $1,221 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,772 | $1,209 | $1,262 | $990 | $1,221 |
| Shareholders' Equity | |||||
| Common Shares | 67 | 67 | 67 | 67 | 67 |
| Retained earnings | 3,037 | 1,996 | 3,274 | 34 | 723 |
| Other shareholders' equity | 873 | 462 | -167 | -513 | 0 |
| TOTAL | $49,071 | $47,535 | $48,037 | $44,439 | $45,451 |
| Total Liabilities And Equity | $50,843 | $48,744 | $49,299 | $45,429 | $46,672 |